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ABSTRACT
The dimeric glycoprotein anti-Mu¨llerian hormone (AMH) is a mem-
ber of the transforming growth factor-b superfamily of growth and
differentiation factors. During male fetal sex differentiation, AMH is
produced by Sertoli cells and induces degeneration of the Mu¨llerian
ducts, which form the anlagen of part of the internal female genital
system. In females, AMH is produced by the ovary, but only postna-
tally. The function of AMH in the ovary is, however, still unknown.
Female AMH null mice were reported to be fertile, with normal litter
size, but this does not exclude a more subtle function for ovarian AMH.
To investigate the function of AMH in the ovary, the complete
follicle population was determined in AMH null mice, in mice het-
erozygous for the AMH null mutation, and in wild-type mice of dif-
ferent ages: 25 days, 4 months, and 13 months. In the present study
we found that ovaries of 25-day- and 4-month-old AMH null females,
compared to those of wild-type females, contain more preantral and
small antral follicles. In addition, in 4- and 13-month-old AMH null
females, smaller numbers of primordial follicles were found. Actually,
in 13-month-old AMH null females, almost no primordial follicles
could be detected, coinciding with a reduced number of preantral and
small antral follicles in these females. In almost all females heterozy-
gous for the AMH null mutation the number of follicles fell in between
the numbers found in wild-type and AMH null females. In 4-month-
old AMH null females serum inhibin levels were higher and FSH
levels were lower compared to those in wild-type females. In contrast,
inhibin levels were lower in 13-month-old AMH null females, and
FSH levels were unchanged compared to those in wild-type females.
Furthermore, the weight of the ovaries was twice as high in the
4-month-old AMH null females as in age-matched wild-type females.
We conclude that AMH plays an important role in primordial
follicle recruitment, such that more primordial follicles are recruited
in AMH null mice than in wild-type mice; the mice heterozygous for
the AMH null mutation take an in-between position. Consequently,
the ovaries of AMH null females and those of females heterozygous
for the AMH null mutation will show a relatively early depletion of
their stock of primordial follicles. The female AMH null mouse may
thus provide a useful model to study regulation of primordial follicle
recruitment and the relation between follicular dynamics and ovarian
aging. (Endocrinology 140: 5789–5796, 1999)
ANTI-MU¨LLERIAN HORMONE (AMH), also calledMu¨llerian-inhibiting substance, is a member of the
transforming growth factor-b superfamily of peptide growth
and differentiation factors (1). During male fetal sex differ-
entiation, AMH is synthesized by testicular Sertoli cells and
induces degeneration of the Mu¨llerian ducts, which form the
anlagen of the uterus, the oviducts, and the upper part of the
vagina (2). During female fetal development, no ovarian
AMH production occurs (3). However, AMH messenger
RNA (mRNA) expression is detected in ovarian granulosa
cells from postnatal day 3 onward (3). Immunohistochemical
(4, 5) and mRNA in situ hybridization (3, 6) studies in rats
revealed specific expression of AMH and its type II receptor
(AMHRII) in granulosa cells of mainly nonatretic preantral
and small antral follicles, whereas the signal was lost in
nonatretic large antral follicles and atretic follicles of all size
classes (6). During the estrous cycle, no marked changes were
detected in the patterns of AMH and AMHRII mRNA ex-
pression, except at estrus, when a heterogeneous decrease in
the expression of both mRNAs was found in nonatretic pre-
antral follicles compared with the more homogeneous ex-
pression pattern on other days of the cycle (6). In cultured rat
granulosa cells, exogenous AMH inhibits biosynthesis of
aromatase and decreases LH receptor number (7). Further-
more, AMH opposes the proliferation of cultured granulosa-
luteal cells (8, 9).
The marked changes in AMH and AMHRII mRNA ex-
pression and the reported effects of AMH in in vitro culture
systems indicate that AMH may play a role during follicle
development in the postnatal ovary. However, little is
known about the exact function of AMH in the ovary. In the
present study the function of AMH in the postnatal ovary has
been studied with the help of an AMH null mouse model
generated by Behringer et al. (10). As in female animals, AMH
and its sole receptor (AMHRII) (11, 12) are predominantly
found in the postnatal ovary, nonovarian effects of the de-
letion of the amh gene are unlikely to occur, and therefore, the
AMH null mouse provides an excellent model for examining
the function of AMH in the mouse ovary. AMH null males
develop Mu¨llerian duct derivatives, including oviducts, a
uterus, and a vagina, in addition to a complete male repro-
ductive system. AMH null females have macroscopically
normal uteri, oviducts, and ovaries. Furthermore, these fe-
males are fertile and have litters of normal size (10). Yet, we
hypothesized that AMH might be involved in subtle and
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long term aspects of control of follicle development and/or
follicle selection. To investigate whether AMH exerts effects
on the composition of the follicle population, we determined
the entire follicle population in wild-type mice [AMH(1/
1)], mice heterozygous for the AMH null mutation
[AMH(1/2)] and AMH null mice [AMH(2/2)] at 25 days,
4 months, and 13 months of age. Other parameters of re-
productive function, such as serum FSH and inhibin levels
and ovarian and uterine weights, were also determined.
We found that AMH is an important regulator of primor-
dial follicle recruitment and that ovaries of AMH null mice
show depletion of primordial follicles at an earlier age.
Materials and Methods
Animals
A single male and a single female AMH(1/2) mouse were obtained
from The Jackson Laboratory (Bar Harbor, ME). This pair was used to
generate F1 mice. Next, several F1 AMH(2/2) males and females were
cross-bred with female and male C57B6 mice to obtain AMH(1/2) mice
on a C57B6 genetic background. Subsequently, these mice were used to
make AMH(1/1), AMH(1/2), and AMH(2/2) mice, which were
used for follicle population analysis. The mice were kept under standard
animal housing conditions in accordance with the NIH Guidelines for
the Care and Use of Experimental Animals. Lights were on from 0730–
2030 h. AMH(1/1) mice, AMH(1/2) mice, and AMH(2/2) mice of
25 days (n 5 4), 4 months (n 5 4), and 13 months (n 5 5) of age were
used for this study. The 4- and 13-month-old animals were killed on the
day of estrus, which was determined by placing the females individually
with an AMH(1/1) male of proven fertility in the afternoon, followed
by a check for a copulatory plug the next morning. Females with a
copulatory plug were killed on the same day at 1600 h by decapitation,
after which blood was collected immediately. Females 25 days old,
which were still prepubertal, were also killed at 1600 h. After bleeding,
the ovaries were removed, weighed, and fixed overnight in Bouin’s fluid
for histological examination of the follicle population. The uterus was
also removed and weighed.
The fixed ovaries were embedded in paraffin after routine histological
procedures, and 8-mm sections were mounted on slides and stained with
hematoxylin and eosin. Blood samples were stored overnight at 4 C and
centrifuged the following day at 3000 rpm for 15 min at 4 C. Serum
samples were stored at 220 C until assayed for FSH and inhibin.
Determination of mouse AMH genotype
To analyze the genotype of the mice, genomic DNA was isolated by
incubating tail tissue overnight at 55 C in 500 ml 50 mm Tris-HCl (pH
8.0), 100 mm EDTA (pH 8.0), 900 mg/ml proteinase K (Roche Molecular
Biochemicals, Mannheim, Germany), and 0.5% (wt/vol) SDS. The next
day, 500 ml phenol (Merck & Co., Darmstadt, Germany) dissolved in
Tris-HCl (pH 8.0) were added, and the mixture was shaken vigorously
for 15 sec. Subsequently, the solution was centrifuged at 13,000 rpm for
10 min. To the supernatant, 200 ml phenol and 200 ml chloroform-isoamyl
alcohol (24:1) were added. After shaking vigorously, the solution was
centrifuged for 10 min at 13,000 rpm. To the supernatant, 2 vol 100%
ethanol were added, and the precipitated DNA was washed with 70%
ethanol. After the DNA was air-dried for a few minutes, it was dissolved
in 100 ml TE buffer (10 mm Tris-HCl, pH 7.5, and 1 mm EDTA, pH 8.0).
Approximately 1 mg DNA was used in the PCR reactions. Primers
KO568 (59-GGAACACAAGCAGAGCTTCC-39) and KO810 (59GAGA-
CAGAGTCCATCACG-ACC-39) were used to determine the presence of
the wild-type allele and were suggested by The Jackson Laboratory
(http://lena.jax.org/resources/documents/imr/protocols/amh_
ko.html). Primer KO568 anneals to nucleotide sequence 568–587 lo-
cated in exon 1 of the amh gene (numbering according to GenBank
sequence, accession number X63240), whereas primer KO810 anneals to
antisense sequence 810–789 located in intron 1, resulting in a PCR
product of 243 bp. In animals containing the AMH null allele, part of
exon 1, intron 1, and exon 2 are replaced by the pCM1 neo-cassette.
Therefore, the PCR product is only produced in DNA of AMH(1/1)
and AMH(1/2) animals, which contain the complete wild-type allele.
Primers p126 (59-CTCGTCAAGAAGGCGATA-39) and p127 (59-
GGGATCGGCAT-TGAACA-39) were used to determine the presence
or absence of the AMH null allele, i.e. the pCM1 neo-cassette (13).
Primer p126 anneals to the antisense sequence 1057–1041, whereas
primer p127 anneals to nucleotide sequence 265–281 in the pCM1
neo-cassette, resulting in a PCR product of 793 bp. Only AMH(1/2)
and AMH(2/2) animals, which contain the pCM1 neo-cassette, will
produce this PCR product. For the PCR reaction, 50 ng of primers
KO568 and KO810 or 100 ng of primers p126 and p127 were used in a
PCR buffer containing 1.2 mm dithiothreitol, 10 mm Tris-HCl (pH 8.3),
50 mm KCl, 1.5 mm MgCl2, 0.25 mm deoxy-NTPs (Pharmacia Biotech,
Uppsala, Sweden), 0.5 mm spermidine (Sigma, St. Louis, MO), and 0.2
U Supertaq (Sphearo Q, Leiden, The Netherlands) in a total volume of
25 ml.
The PCR reaction mixtures were preheated at 94 C for 5 min followed
by 30 PCR cycles (1-min denaturation at 94 C, 1-min annealing at 58 C
for the wild-type allele and 1-min annealing at 62 C for the null allele, 1-min
extension at 72 C) and a final extension step of 10 min at 72 C. The DNA
control PCR was carried out as previously described by Slegtenhorst et al.
(14). The products were electrophoresed on a 1.5% agarose gel.
Estrous cycle length
Daily vaginal smears were taken of female mice belonging to the three
different genotypes for a continuous period of 40 days, beginning at 3–4
months of age (n 5 10/group), to assess cycle length and the regularity
of the cycle. Dried smears were examined microscopically, and the stage
of the estrous cycle was determined according to the criteria of Allen
(15). The females were housed individually in cages placed next to a cage
containing an adult AMH(1/1) male.
Ovarian histology and follicle counting
Serial 8-mm sections of both ovaries were used for follicle counting.
All primordial follicles were counted in every second section. Based on
the mean diameter of the follicle, which was determined by measuring
two perpendicular diameters in the section in which the nucleolus of the
oocyte was present, the growing follicles were divided into two classes,
i.e. small and large follicles. The small follicle class contains preantral and
small antral follicles with a diameter smaller than 310 mm, and the large
follicle class contains antral follicles with a diameter larger than 310 mm.
The number of large follicles was very small in females of all three ages.
This was expected, as in immature 25-day-old animals growing follicles
become atretic before they reach this stage of follicular development (16)
and the cycling animals of 4 and 13 months of age were killed on the day
of estrus, a time point during the estrous cycle when no large follicles
have developed (17, 18).
Nonatretic and atretic follicles were counted separately. The criteria
for atresia were the presence of pyknotic nuclei in the granulosa cells
and/or degeneration of the nucleus of the oocyte (18, 19). For all three
genotypes we found degenerating, i.e. fragmented oocytes, which are the
remnants of atretic follicles (19). No diameter could be determined for
these follicle remnants, because the layer of granulosa cells could not be
distinguished very well from the surrounding interstitial tissue. To
prevent double counting of these follicle remnants, which we called
atretic oocytes, these oocytes were counted in every tenth section. The
atretic oocytes were classified as a separate group.
In addition, the total number of fresh corpora lutea was counted in
the 4- and 13-month-old animals. Newly formed corpora lutea could be
distinguished from the older ones by their smaller size of luteal cells.
Measurements of serum FSH and inhibin
Serum FSH was determined by RIA using rat FSH as a ligand and
antibodies against ovine FSH (20). All results are expressed in terms of
NIDDK rat FSH RP-2. The intraassay variation was 8.8%, and all samples
were measured in one assay.
Serum inhibin-like immunoreactivity was estimated using the
method described by Robertson et al. (21), with a bovine follicular fluid
preparation with an arbitrary potency of 1 U/mg protein as standard
(22). The antibody was raised against purified 32-kDa bovine follicular
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fluid inhibin and cross-reacts with free a-subunits. All samples were run
in the same assay, and the intraassay coefficient of variation was 8.2%.
Statistical analysis
Results are presented as the mean 6 sem. The data were evaluated
for statistical differences by one-way ANOVA, followed by Duncan’s
new multiple range test using SPSS 7.5 (SPSS, Inc., Chicago, IL) computer
software. Differences were considered significant at P # 0.05.
Results
Estrous cycle length
Vaginal smears were taken daily for a period of 40 days to
determine the length and regularity of the estrous cycle in
AMH(1/1), AMH(1/2), and AMH(2/2) female mice. No
differences were found among these three groups of mice in
either the length or the regularity of the estrous cycle. In all
three groups some animals showed at least one prolonged
estrous cycle (varying from 8–22 days) in which several
metestrous or diestrous smears were obtained. However, no
consistent differences among the three genotypes were ob-
served. In all groups regular estrous cycles with a length of
4–6 days were found (results not shown).
Weights of ovaries and uterus
Uterine and ovarian weights were determined to obtain an
indication of whether AMH had some effect on development
of the uterus and the ovary. Furthermore, uterine weight is
an estrogen-sensitive parameter and thus may also give an
indication of ovarian function.
At all ages no statistical difference was found in uterine
weight among the three genotypes (Table 1). No difference
in the weight of the ovaries among the three groups was
found at 25 days and 13 months of age. At the age of 4
months, however, the weights of the two ovaries were about
1.8-fold higher in the AMH(2/2) females than in
AMH(1/1) mice. It is of interest to note that the ovarian
weight of AMH(1/2) females fell in between the weights of
the ovaries of AMH(1/1) and AMH(2/2) mice (Fig. 1).
Ovarian morphology
The ovaries of all genotypes contained primordial, pre-
antral, and small antral follicles, both nonatretic and atretic.
In 4- and 13-month-old animals both fresh and old corpora
lutea were present, indicating an active estrous cycle. At all
ages, atretic oocytes were found in the interstitium (Fig. 2C).
Figure 2, A and B, illustrates that in a 25-day-old AMH(2/2)
mouse ovary many small follicles were found, whereas a
13-month-old AMH(2/2) mouse ovary contained very few
small follicles. At this latter age, the main part of the ovary
consists of interstitial tissue and corpora lutea. For ovaries of
age-matched AMH(1/1) and AMH(1/2) females similar
histology was observed, as reported previously by Behringer
et al. (10).
Follicle counts
To test the hypothesis that AMH might play a role in
follicle maturation or selection, the entire follicle population
in 25-day-, 4-month-, and 13-month-old AMH(1/1),
AMH(1/2), and AMH(2/2) female mice was determined
(Fig. 3, A–C). Note the differences in scale of the y-axis among
the different graphs in Fig. 3, A–C.
In 25-day-old females no significant difference in the num-
ber of primordial follicles among AMH(1/1), AMH(1/2),
and AMH(2/2) females was detected (Fig. 3A). However,
compared with the ovaries of AMH(1/1) females of 4 and
13 months of age, the ovaries of age-matched AMH(2/2)
females contained a significantly smaller number of primordial
follicles (Fig. 3, B and C). In fact, at 13 months of age the number
of primordial follicles was reduced in AMH(2/2) females to
38 6 15, whereas in the AMH(1/1) females the average num-
ber of primordial follicles was 225 6 52 (Fig. 3C).
For the category of nonatretic small follicles the
AMH(2/2) females at the age of 25 days showed a marked
increase of approximately 1.5-fold compared with that in the
AMH(1/1) mice (Fig. 3A). In 4-month-old AMH(2/2) fe-
males an approximately 3-fold increase in the number of
TABLE 1. Uterine weight in AMH (1/1), AMH (1/2), and AMH
(2/2) female mice of 25 days, 4 months, and 13 months of age
Age Genotype Uterus wt (mg)
25 days (n 5 4) AMH (1/1) 16.0 6 3.0
AMH (1/2) 17.0 6 3.0
AMH (2/2) 11.0 6 1.0
4 months (n 5 4) AMH (1/1) 130.0 6 8.0
AMH (1/2) 114.9 6 9.2
AMH (2/2) 88.9 6 7.0
13 months (n 5 5) AMH (1/1) 210.5 6 32.2
AMH (1/2) 213.8 6 18.7
AMH (2/2) 165.6 6 24.5
Values represent the mean 6 SEM.
FIG. 1. Ovarian weight in 25-day-, 4-month-, and 13-month-old
AMH(2/2), AMH(1/2), and AMH(1/1) female mice. The combined
weight of both ovaries is given. At 4 months of age, ovarian weight was
significantly higher in AMH(2/2) females than in AMH(1/1) fe-
males. Data represent the mean 6 SEM (n 5 4–5). The asterisk in-
dicates a statistically significant difference (P # 0.05).
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nonatretic small follicles was found compared with that in
the AMH(1/1) females (Fig. 3B). This 3-fold increase in
follicle number was also found for the atretic small follicles.
In contrast, significantly fewer nonatretic and atretic small
follicles were counted in the 13-month-old AMH(2/2) fe-
males (Fig. 3C). The number of atretic oocytes in 4-month-old
AMH(2/2) females was about 4-fold larger than that in
AMH(1/1) females (Fig. 3B). In the three groups of mice at
the three different ages the average numbers of 0.9 6 0.2
nonatretic large follicle and 0.8 6 0.2 atretic large follicle were
found (results not shown).
In almost all instances the number of follicles present in
AMH(1/2) females fell in between the numbers found in
the AMH(1/1) and AMH(2/2) females (Fig. 3, A–C).
Number of fresh corpora lutea
To determine whether there are any differences among the
three genotypes in the number of ovulations during the last
estrous cycle, the number of fresh corpora lutea were
counted in the 4- and 13-month-old females. At both 4 and
13 months of age no significant differences among the three
groups of mice were found, and an average of 10 fresh
corpora lutea were present (results not shown).
Measurement of serum FSH and inhibin levels
In 4-month-old AMH(2/2) females the serum inhibin
level was 2-fold higher than that in AMH(1/1) females of
the same age, whereas in 13-month-old AMH(2/2) females
the inhibin serum level was 2-fold lower (Table 2). No sta-
tistically significant difference was found in inhibin values in
25-day-old females of the three genotypes. For the serum FSH
level, a statistically significant difference was found only for
AMH(2/2) females of 4 months of age, which showed a de-
creased level compared with AMH(1/1) animals (Table 2).
Discussion
Although AMH has a clear function during male fetal
development (23), its action in the female is still undefined.
Although in the female, AMHRII mRNA expression is al-
ready present in the ovary and the mesenchymal cells sur-
rounding the Mu¨llerian ducts before birth (24, 25), AMH
mRNA expression is only found after birth in the ovary.
Postnatally, both mRNA species are highly expressed in
granulosa cells of mainly nonatretic preantral and small an-
tral follicles (3, 6). This expression pattern does not change
during the estrous cycle, except at estrus, when a more het-
erogeneous pattern becomes apparent and the expression of
AMH mRNA is lower in some nonatretic preantral follicles.
This expression pattern may indicate a role for AMH in the
regulation of follicle selection or maturation (6). Such a role
is supported by the findings that AMH has inhibitory effects
on granulosa cell proliferation (8, 9), aromatase activity, and
LH receptor expression (7).
In the present study a possible role for AMH in the ovary
was examined by comparing the entire ovarian follicle pop-
ulation of AMH(1/1) mice with the follicle populations of
AMH(2/2) and AMH(1/2) mice. Ovaries of 25-day-,
4-month, and 13-month-old females were examined. These
FIG. 2. Photomicrographs of ovarian histology. A, Ovary of a 25-day-
old AMH(2/2) female mouse. Many nonatretic (arrowhead) and
atretic (asterisk) small follicles are present, whereas no corpora lutea
can be detected. Scale bar, 250 mm. B, Ovary of a 13-month-old
AMH(2/2) female mouse. The ovary mainly consists of interstitium
(I), and old (OCL) and fresh corpora lutea (FCL). Only a few small
follicles are present (arrowhead). Scale bar, 250 mm. C, Atretic oocyte
from a 25-day-old AMH(2/2) mouse ovary. The oocyte (AO) has re-
sumed its meiotic division and has lost its round shape. Around the
oocyte no clear granulosa and thecal cell layers can be distinguished.
Both the granulosa cell layer (GC) and the thecal cell layer (TC) are
present in the follicle adjacent to the atretic oocyte. Scale bar, 50 mm.
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FIG. 3. Follicle population in 25-day-,
4-month-, and 13-month-old AMH(2/
2), AMH(1/2), and AMH(1/1) female
mice. A, Follicle populations in 25-day-
old AMH(2/2), AMH(1/2), and
AMH(1/1) female mice. Significantly
more nonatretic small follicles were de-
tected in AMH(1/2) and AMH(2/2) fe-
males than in AMH(1/1) females. No
significant difference in the number of
primordial follicles, atretic small folli-
cles, or atretic oocytes was observed
among the three groups of mice. B, Fol-
licle population in 4-month-old AMH(2/
2), AMH(1/2), and AMH(1/1) female
mice. Significantly fewer primordial fol-
licles and significantly more nonatretic
small follicles were found in AMH(2/2)
and AMH(1/1) females than in
AMH(1/2) females. Significantly more
atretic small follicles were found in
AMH(2/2) females than in the two
other groups of females, whereas sig-
nificantly more atretic oocytes were
found in AMH(2/2) and AMH(1/2)
females than in AMH(1/1) females.
C, Follicle population in 13-month-
old AMH(2/2), AMH(1/2), and
AMH(1/1) female mice. Significantly
fewer primordial and nonatretic and
atretic small follicles were found in
AMH(2/2) females than in AMH(1/1)
females. Data represent the mean 6
SEM (n 5 4–5). An asterisk indicates a
statistically significant difference (P #
0.05).
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ages were chosen to represent three different stages in the
reproductive life of the female mouse. At 25 days of age,
female mice are prepubertal and do not have estrous cycles;
at 4 months of age, the females are at the height of their
reproductive life; and at 13 months of age, the females have
almost reached reproductive cessation (26).
Upon characterization of the complete follicle population
in AMH(1/1), AMH(1/2), and AMH(2/2) animals, the
results indicate that the number of primordial follicles de-
creases with age in the three groups of mice. However, in
AMH(2/2) females, the pool of primordial follicles de-
creases faster than in AMH(1/1) mice. Although in 25-day-
old females no significant differences were found in the
number of primordial follicles between AMH(1/1) and
AMH(2/2) females, at 4 and 13 months of age, the number
of primordial follicles was significantly smaller in
AMH(2/2) females. The absence of a difference in the pri-
mordial follicle number in prepubertal mice indicates that
AMH may not have a role in the pronounced wave of attri-
tion of follicles that occurs before regular estrous cycles start
(27). One way by which the smaller number of primordial
follicles in AMH(2/2) females of 4 and 13 months of age
may be explained is a loss of primordial follicles from the
stock through degeneration by attrition. The extent of this
phenomenon, however, is difficult to measure, because ad-
equate morphological markers of degeneration in primordial
follicles are lacking (28). Furthermore, degenerated primor-
dial follicles may be eliminated very rapidly from the ovary,
preventing an accurate determination of their number (29).
An alternative explanation for the smaller number of pri-
mordial follicles found in 4- and 13-month-old AMH(2/2)
females compared with AMH(1/1) females could be an
increased number of estrous cycles within a certain time
period in AMH(2/2) females. However, no difference in the
length or the regularity of the estrous cycle among the three
genotypes at 3–4 months of age was detected. Yet another
explanation would be that in AMH(2/2) animals, more
primordial follicles are recruited to enter the pool of growing
follicles. This explanation is favored on the basis of the
present observations of increased numbers of nonatretic and
atretic small follicles in AMH(2/2) females of 25 days and
4 months of age compared with the age-matched
AMH(1/1) control mice.
The larger number of small follicles in 4-month-old
AMH(2/2) females might lead to a larger number of ovu-
lations per cycle and subsequently to larger litters. However,
we have not found any difference in the size of the litters
derived from AMH(2/2), AMH(1/2), or AMH(1/1) fe-
males (results not shown), which is consistent with the pre-
viously published report (10). However, to exclude the pos-
sibility of increased embryonic death in utero in 4-month-old
AMH(2/2) females, we determined the number of ovula-
tions by counting the number of fresh corpora lutea that
emerge from the preovulatory follicles after recent ovulation.
Again, no difference was detected in the number of fresh
corpora lutea between the ovaries of 4-month-old
AMH(2/2) females and the age-matched females from the
two other groups, which excludes a higher ovulation rate in
the absence of AMH. These results suggest that in the ab-
sence of AMH action, increased atresia of small follicles may
result in loss of an increased percentage of growing follicles,
so that finally the number of these follicles that reach the
preovulatory stage is approximately equal in AMH(2/2)
and AMH(1/1) mice. Indeed, in 4-month-old AMH(2/2)
ovaries we found significantly more atretic small follicles
than in AMH(1/1) ovaries. However, the number of non-
atretic small follicles showed a similar increase. Thus, in the
AMH(2/2) females more atretic small follicles were found,
probably because in these animals more nonatretic small
follicles were being produced. In addition, the number of
atretic oocytes, which are thought to arise from atretic fol-
licles, is larger in AMH(2/2) females of 4 months of age,
indicating that in AMH(2/2) females the larger number of
small nonatretic follicles is compensated by more atretic fol-
licles. Thus, increased atresia results in similar numbers of
preovulatory follicles and ovulations in AMH(2/2) and
AMH(1/1) female mice. Higher rates of atresia may also
exist at other days of the cycle, which we have not studied;
therefore, further studies are necessary to elucidate this point.
From 4 to 13 months of age the number of nonatretic small
follicles in AMH(2/2) females shows a marked decline. This
is in accordance with the very small number of primordial
follicles that are still present in the ovaries of 13-month-old
AMH(2/2) females. This smaller number of nonatretic small
follicles is not associated with a smaller number of fresh corpora
lutea still being formed in these females. This may be explained
by more efficient growth of follicles to the preovulatory stage,
as indicated by the significantly lower percentage of atretic
small follicles in the 13-month-old AMH(2/2) females.
It is of interest to note that in almost all animals the number
of follicles per class in the AMH(1/2) females fell in be-
tween the numbers found for AMH(1/1) and AMH(2/2)
females. For other gene knockout animal models, such as
activin null mice or FSH null mice (30, 31), such a gene dosage
effect has not been reported. Moreover, Mu¨llerian duct re-
gression in male AMH(1/2) mice occurs to the same extent
as in AMH(1/1) males (10). The AMH gene dose depen-
dency observed in the present study may indicate that ovar-
ian AMH production or secretion is not under stringent
feedback control, but, rather, depends on the intrinsic activ-
ity of the gene itself.
The results presented herein indicate that AMH exerts an
inhibitory effect on recruitment of primordial follicles into
TABLE 2. Serum inhibin immunoreactivity and FSH levels in
AMH (1/1), AMH (1/2), and AMH (2/2) female mice of 25 days,
4 months, and 13 months of age
Age Genotype Inhibin a-subunit(U/ml) FSH (ng/ml)
25 days (n 5 4) AMH (1/1) 33.9 6 5.8 24.1 6 5.3
AMH (1/2) 28.9 6 4.8 17.7 6 1.5
AMH (2/2) 25.0 6 2.2 15.0 6 1.8
4 months (n 5 4) AMH (1/1) 20.6 6 1.6 39.7 6 2.6
AMH (1/2) 35.2 6 1.5a 31.5 6 2.8
AMH (2/2) 43.5 6 4.0a 27.9 6 2.9a
13 months (n 5 5) AMH (1/1) 21.5 6 1.6 28.8 6 2.6
AMH (1/2) 12.6 6 3.8a 31.3 6 2.9
AMH (2/2) 11.5 6 0.9a 37.9 6 3.8
Values represent the mean 6 SEM.
a Significantly different from AMH (1/1) in the same age group
(P , 0.05), evaluated by Duncan’s new multiple range test.
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the pool of growing follicles. A direct effect of AMH on the
primordial follicles themselves cannot be excluded, although
no information is available that clearly demonstrates AMH
type II receptor expression in these follicles. Alternatively,
the primary action of AMH may be autocrine in nature, as
granulosa cells of small follicles express both AMH and its
type II receptor. The small follicles may be stimulated by
AMH to produce a factor(s) that acts on primordial follicles.
Little is known about the factors that control the release of
primordial follicles from their quiescent state. Primordial
follicles can be considered the ovarian follicle stock, and this
reserve of dormant follicles is not renewable (26). Through-
out neonatal life and continuing through the reproductive
life span, follicles leave the stock of primordial follicles in a
continuous stream and begin to grow, thus depleting the
original pool of primordial follicles with age (26, 29). There
are indications that the recruitment of primordial follicles
into the growing pool is influenced by the total size of the
nongrowing pool of primordial follicles itself (32). Thus, a
decrease in the number of remaining primordial follicles is
accompanied by an increase in their depletion rate (29). De-
spite the fact that the gonadotropins FSH and LH predom-
inantly act on recruited antral follicles (33), several studies
show that gonadotropins influence the size of the primordial
follicle pool. Hypophysectomy, for example, slows the loss
of primordial follicles, implicating a role of pituitary factors,
such as the gonadotropins, in the control of growth initiation
of primordial follicles (34). FSH may accelerate the initiation
of the growth of primordial follicles. Unilateral ovariectomy
in aged rats causes increased FSH serum levels and concom-
itant increased loss of primordial follicles (35), whereas in aging
rats, in which primordial follicles are lost at an accelerated rate
(36), both LH and FSH levels are increased compared with the
levels in young females (37). In transgenic mice that maintain
a chronically elevated serum LH level, the primordial follicle
pool is depleted faster (38). A direct effect of FSH and LH on the
primordial follicles themselves, however, appears to be un-
likely, as several studies were unsuccessful in detecting full-
length LH and FSH receptor mRNA expression in primordial
follicles (39–42). In contrast, gonadotropins are not essential for
the initiation of primordial follicle growth. In FSH null females
primordial follicles are recruited and grow into preantral fol-
licles (31), and primordial follicle recruitment also occurs in
cultured newborn mouse ovaries without the addition of go-
nadotropins to the culture medium (43).
Despite their advanced age and the small number of pri-
mordial follicles present in their ovaries, we found that the
13-month-old females of the three different genotypes had
not yet reached the period of acyclicity. Although the estrous
cycle in these animals was not checked with the help of
vaginal smears, we conclude this from the fact that in the
ovaries of 13-month-old females an average of 10 fresh cor-
pora lutea were found, which is the same average number as
found in 4-month-old females.
The ovaries from 4-month-old AMH(2/2) mice were
heavier than the ovaries of control animals. Although most
often the total mass of the corpora lutea largely determines
the weight of an ovary, the numbers of corpora lutea were
similar in the animals of the three genotypes, suggesting that
the increase in ovarian weight in the AMH(2/2) females is
caused by the 3-fold larger number of small follicles. In
25-day- and 13-month-old animals no significant differences
were observed in ovarian weight among the three genotypes,
which is in line with the much smaller differences in the
number of small follicles found in these animals. No differ-
ence was found among the three groups of mice in uterine
weight, which indicates that the estrogen levels in the
AMH(1/1), AMH(1/2), and AMH(2/2) are similar.
The large number of small follicles in the 4-month-old
AMH(2/2) mice may also explain the changes in serum
levels of FSH (decrease) and inhibin immunoreactivity (in-
crease) in these animals. In mouse preantral follicles, both
inhibin A and inhibin B are produced (44, 45), whereas small
antral follicles mainly produce inhibin B, and large antral
follicles mainly produce inhibin A (46, 47). Despite the fact
that only the inhibin immunoreactivity level was measured
in the serum samples, we suggest that the increased number
of small follicles in the AMH(2/2) females is also respon-
sible for an increase in bioactive dimeric inhibin A or B,
which, in turn, suppresses both FSH synthesis and FSH re-
lease from the pituitary gland (48). The reduced FSH level in
AMH(2/2) females of 4 months of age might prevent the
larger number of small antral follicles in these animals to
develop to the preovulatory follicle stage. Indeed, if the FSH
level was not lower in AMH(2/2) females, an increase in
litter size in these mice might have been expected. The larger
number of growing follicles accompanied by a decrease in
FSH is an intriguing observation, as FSH stimulates preantral
follicle development (49–51), although the vast majority of
the effects of FSH are on the recruited, antral pool of follicles
(33). A possible explanation might be that small follicles may
be more sensitive to FSH in the absence of AMH. Alterna-
tively, AMH may be instrumental in inhibition of the pro-
duction and/or activity of a factor(s) important for preantral
follicle development. Candidates for such factors are growth
and differentiation factor-9 (GDF-9) and bone morphoge-
netic protein-15 (BMP-15), which both are members of the
transforming growth factor-b superfamily. GDF-9 is an oo-
cyte-specific growth factor, and in mice lacking GDF-9 there
is an early block in folliculogenesis at the one-layer primary
follicle stage (52). Recently, it has been shown that recom-
binant GDF-9 is able to enhance the growth and differenti-
ation of cultured small preantral follicles (53). BMP-15 is most
closely related to and shares a coincident expression pattern
with GDF-9, which could imply that BMP-15 is also neces-
sary for preantral follicle development (54). Thus, AMH
might have an effect on expression of GDF-9 and/or BMP-15,
thereby influencing preantral follicle development.
In conclusion, the study of ovaries of AMH null mice
indicates that ovarian AMH directly or indirectly prevents or
inhibits primordial follicles to enter the pool of growing
follicles. As impaired recruitment of primordial follicles may
be the underlying cause of human diseases such as prema-
ture ovarian failure (55), it will be of great interest to study
the role of AMH in the physiology of the human ovary.
Acknowledgments
The authors thank Marianna Timmerman for the determination of
serum inhibin and FSH levels.
AMH AND PRIMORDIAL FOLLICLE RECRUITMENT 5795
 at Medical Library Erasmus MC on December 4, 2006 endo.endojournals.orgDownloaded from 
References
1. Cate RL, Mattaliano RJ, Hession C, Tizard R, Farber NM, Cheung A, Ninfa EG,
Frey AZ, Gash DJ, Chow EP, Fischer RA, Bertonis JM, Torres G, Wallner BP,
Ramachandran KL, Ragin RC, Manganaro TF, MacLaughlin DT, Donahoe PK
1986 Isolation of the bovine and human genes for mu¨llerian inhibiting substance
and expression of the human gene in animal cells. Cell 45:685–698
2. Munsterberg A, Lovell-Badge R 1991 Expression of the mouse anti-Mu¨llerian
hormone gene suggests a role in both male and female sexual differentiation.
Development 113:613–624
3. Hirobe S, He WW, Lee MM, Donahoe PK 1992 Mu¨llerian inhibiting substance
messenger ribonucleic acid expression in granulosa and Sertoli cells coincides
with their mitotic activity. Endocrinology 131:854–862
4. Ueno S, Kuroda T, Maclaughlin DT, Ragin RC, Manganaro TF, Donahoe PK
1989 Mu¨llerian inhibiting substance in the adult rat ovary during various
stages of the estrous cycle. Endocrinology 125:1060–1066
5. Ueno S, Takahashi M, Manganaro TF, Ragin RC, Donahoe PK 1989 Cellular
localization of Mullerian inhibiting substance in the developing rat ovary.
Endocrinology 124:1000–1006
6. Baarends WM, Uilenbroek JT, Kramer P, Hoogerbrugge JW, van Leeuwen
EC, Themmen AP, Grootegoed JA 1995 Anti-Mullerian hormone and anti-
Mullerian hormone type II receptor messenger ribonucleic acid expression in
rat ovaries during postnatal development, the estrous cycle, and gonado-
tropin-induced follicle growth. Endocrinology 136:4951–4962
7. di Clemente N, Goxe B, Re´my JJ, Cate RL, Josso N, Vigier B, Salesse R 1994
Inhibitory effect of AMH upon the expression of aromatase and LH receptors
by cultured granulosa cells of rat and porcine immature ovaries. Endocrine
2:553–558
8. Kim JH, Seibel MM, MacLaughlin DT, Donahoe PK, Ransil BJ, Hametz PA,
Richards CJ 1992 The inhibitory effects of Mullerian-inhibiting substance on
epidermal growth factor induced proliferation and progesterone production
of human granulosa-luteal cells. J Clin Endocrinol Metab 75:911–917
9. Seifer DB, MacLaughlin DT, Penzias AS, Behrman HR, Asmundson L,
Donahoe PK, Haning Jr RV, Flynn SD 1993 Gonadotropin-releasing hormone
agonist-induced differences in granulosa cell cycle kinetics are associated with
alterations in follicular fluid mu¨llerian-inhibiting substance and androgen
content. J Clin Endocrinol Metab 76:711–714
10. Behringer RR, Finegold MJ, Cate RL 1994 Mu¨llerian-inhibiting substance
function during mammalian sexual development. Cell 79:415–425
11. Mishina Y, Rey R, Finegold MJ, Matzuk MM, Josso N, Cate RL, Behringer
RR 1996 Genetic analysis of the Mu¨llerian-inhibiting substance signal trans-
duction pathway in mammalian sexual differentiation. Genes Dev
10:2577–2587
12. Mishina Y, Whitworth DJ, Racine C, Behringer RR 1999 High specificity of
Mullerian-inhibiting substance signaling in vivo. Endocrinology 140:2084–2088
13. Thomas KR, Capecchi MR 1987 Site-directed mutagenesis by gene targeting
in mouse embryo-derived stem cells. Cell 51:503–512
14. Slegtenhorst-Eegdeman KE, de Rooij DG, Verhoef-Post M, van de Kant HJ,
Bakker CE, Oostra BA, Grootegoed JA, Themmen AP 1998 Macroorchidism
in FMR1 knockout mice is caused by increased Sertoli cell proliferation during
testicular development. Endocrinology 139:156–162
15. Allen E 1922 The oestrus cycle in the mouse. Am J Anat 30:297–371
16. Sander HJ, Meijs-Roelofs HM, van Leeuwen EC, Kramer P, van Cappellen
WA 1986 Inhibin increases in the ovaries of female rats approaching first
ovulation: relationships with follicle growth and serum FSH concentrations. J
Endocrinol 111:159–166
17. Welschen R, Rutte M 1971 Ovulation in adult rats after treatment with preg-
nant mare serum gonadotrophin during oestrus. Acta Endocrinol (Copenh)
68:41–49
18. Osman P 1985 Rate and course of atresia during follicular development in the
adult cyclic rat. J Reprod Fertil 73:261–270
19. Byskov AG 1974 Cell kinetic studies of follicular atresia in the mouse ovary.
J Reprod Fertil 37:277–285
20. Dullaart J, Kent J, Ryle M 1975 Serum gonadotrophin concentrations in
infantile female mice. J Reprod Fertil 43:189–192
21. Robertson DM, Hayward S, Irby D, Jacobsen J, Clarke L, McLachlan RI, de
Kretser DM 1988 Radioimmunoassay of rat serum inhibin: changes after
PMSG stimulation and gonadectomy. Mol Cel Endocrinol 58:1–8
22. Grootenhuis AJ, Steenbergen J, Timmerman MA, Dorsman AN, Schaaper
WM, Meloen RH, de Jong FH 1989 Inhibin and activin-like activity in fluids
from male and female gonads: different molecular weight forms and bioac-
tivity/immunoactivity ratios. J Endocrinol 122:293–301
23. Jost A 1953 Problems of fetal endocrinology: the gonadal and hypophyseal
hormones. Recent Prog Horm Res 8:349–418
24. di Clemente N, Wilson C, Faure E, Boussin L, Carmillo P, Tizard R, Picard
J, Vigier B, Josso N, Cate R 1994 Cloning, expression, and alternative splicing
of the receptor for anti-mu¨llerian hormone. Mol Endocrinol 8:1006–1020
25. Baarends WM, van Helmond MJ, Post M, van der Schoot PJ, Hoogerbrugge
JW, de Winter JP, Uilenbroek JT, Karels B, Wilming LG, Meijers JH, Them-
men AP, Grootegoed JA 1994 A novel member of the transmembrane serine/
threonine kinase receptor family is specifically expressed in the gonads and in
mesenchymal cells adjacent to the mu¨llerian duct. Development 120:189–197
26. Gosden RG, Laing SC, Felicio LS, Nelson JF, Finch CE 1983 Imminent oocyte
exhaustion and reduced follicular recruitment mark the transition to acyclicity
in aging C57BL/6J mice. Biol Reprod 28:255–260
27. Pedersen T 1970 Determination of follicle growth rate in the ovary of the
immature mouse. J Reprod Fertil 21:81–93
28. Edwards RG, Fowler RE, Gore-Langton RE, Gosden RG, Jones EC, Readhead
C, Steptoe PC 1977 Normal and abnormal follicular growth in mouse, rat and
human ovaries. J Reprod Fertil 51:237–263
29. Hirshfield AN 1994 Relationship between the supply of primordial follicles
and the onset of follicular growth in rats. Biol Reprod 50:421–428
30. Matzuk M, Kumar T, Bradley A 1995 Different phenotypes for mice deficient
in either activins or activin receptor type II. Nature 374:311–312
31. Kumar T, Wang Y, Lu N, Matzuk M 1997 Follicle stimulating hormone is
required for ovarian follicle maturation but not for male fertility. Nat Genet
15:201–204
32. Cran DG, Moor RM 1980 The development of oocytes and ovarian follicles of
mammals. Sci Prog 66:371–383
33. Hirschfield AN, 1991 Development of follicles in the mammalian ovary. Int
Rev Cytol 124:43–101
34. Meredith S, Kirkpatrick-Keller D, Butcher RL 1986 The effects of food re-
striction and hypophysectomy on numbers of primordial follicles and con-
centrations of hormones in rats. Biol Reprod 35:68–73
35. Meredith S, Dudenhoeffer G, Butcher RL, Lerner SP, Walls T 1992 Unilateral
ovariectomy increases loss of primordial follicles and is associated with in-
creased metestrous concentration of follicle-stimulating hormone in old rats.
Biol Reprod 47:162–168
36. Richardson SJ, Senikas V, Nelson JF 1987 Follicular depletion during the
menopausal transition: evidence for accelerated loss and ultimate exhaustion.
J Clin Endocrinol Metab 65:1231–1237
37. Marcus M, Grunfeld L, Berkowitz G, Kaplan P, Godbold J 1993 Urinary
follicle-stimulating hormone as a biological marker of ovarian toxicity. Fertil
Steril 59:931–933
38. Flaws JA, Abbud R, Mann RJ, Nilson JH, Hirshfield AN 1997 Chronically
elevated luteinizing hormone depletes primordial follicles in the mouse ovary.
Biol Reprod 57:1233–1237
39. Teerds KJ, Dorrington JH 1995 Immunolocalization of transforming growth
factor a and luteinizing hormone receptor in healthy and atretic follicles of the
adult rat ovary. Biol Reprod 52:500–508
40. O’Shaughnessy P, Dudley K, Rajapaksha WR 1996 Expression of follicle
stimulating hormone-receptor mRNA during gonadal development. Mol Cell
Endocrinol 125:169–175
41. O’Shaughnessy P, McLelland D, McBride MW 1997 Regulation of luteinizing
hormone-receptor and follicle-stimulating hormone-receptor messenger ribo-
nucleic acid levels during development in the neonatal mouse ovary. Biol
Reprod 57:602–608
42. Oktay K, Briggs D, Gosden RG 1997 Ontogeny of follicle-stimulating hor-
mone receptor gene expression in isolated human ovarian follicles. J Clin
Endocrinol Metab 82:3748–3751
43. Eppig JJ, O’Brien MJ 1996 Development in vitro of mouse oocytes from
primordial follicles. Biol Reprod 54:197–207
44. O’Shaughnessy PJ, Gray SA 1995 Gonadotropin-dependent and gonado-
tropin-independent development of inhibin subunit messenger ribonucleic
acid levels in the mouse ovary. Endocrinology 136:2060–2065
45. Smitz J, Cortvrind R 1998 Inhibin A and B secretion in mouse preantral follicle
culture. Hum Reprod 13:927–935
46. Merchenthaler I, Culler MD, Petrusz P, Negro-Vilar A 1987 Immunocyto-
chemical localization of inhibin in rat and human reproductive tissues. Mol
Cell Endocrinol 54:239–243
47. Meunier H, Cajander SB, Roberts VJ, Rivier C, Sawchenko PE, Hsueh AJ, Vale
W 1988 Rapid changes in the expression of inhibin a-, bA-, and bB-subunits in
ovarian cell types during rat estrous cycle. Mol Endocrinol 2:1352–1363
48. De Jong FH 1988 Inhibin. Physiol Rev 68:555–607
49. Arendsen de Wolff-Exalto E 1982 Influence of gonadotrophins on early follicle
cell development and early oocyte growth in the immature rat. J Reprod Fertil
66:537–542
50. Van Cappellen WA, Meijs-Roelofs HM, Kramer P, Van den Dungen HM 1989
Ovarian follicle dynamics in immature rats treated with a luteinizing hormone-
releasing hormone antagonist (Org. 30276). Biol Reprod 40:1247–1256
51. McGee EA, Perlas E, LaPolt PS, Tsafriri A, Hsueh AJ 1997 Follicle-stimulating
hormone enhances the development of preantral follicles in juvenile rats. Biol
Reprod 57:990–998
52. Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N, Matzuk MM 1996
Growth differentiation factor-9 is required during early ovarian folliculogen-
esis. Nature 383:531–535
53. Hayashi M, McGee E, Min G, Klein C, Rose U, Duin van M, Hsueh A 1999
Recombinant growth and differentiation factor-9 (GDF-9) enhances growth and
differentiation of cultured early ovarian follicles. Endocrinology 140:1236–1244
54. Dube J, Wang P, Elvin J, Lyons K, Celeste A, Matzuk M 1998 The bone
morphogenetic protein 15 is X-linked and expressed in oocytes. Mol Endo-
crinol 12:1809–1817
55. Christin-Maitre S, Vasseur C, Portnoi M, Bouchard P 1998 Genes and pre-
mature ovarian failure. Mol Cell Endocrinol 145:75–80
5796 AMH AND PRIMORDIAL FOLLICLE RECRUITMENT Endo • 1999
Vol 140 • No 12
 at Medical Library Erasmus MC on December 4, 2006 endo.endojournals.orgDownloaded from 
